drugset / Trial / NCT00308100
Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation
RandomizedParallel-groupOpen-labelTreatment
Summary
There are no standardized plasma volume replacement protocols during liver transplantation surgery. The current study is designed to compare efficacy, safety, and costs of perioperative volume replacement with Voluven (Hydroxyethyl starch 130/0.4) and albumin in patients undergoing liver transplantation.
Timeline
- Start
- 2005-10
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Albumin | Protein / enzyme biologic | — | — |
| Subject | Volulyte | Other / unclassified | 33 unknown | — |
Indications
No indication recorded.